112 related articles for article (PubMed ID: 1372785)
1. Pharmacology of bepridil.
Gill A; Flaim SF; Damiano BP; Sit SP; Brannan MD
Am J Cardiol; 1992 Apr; 69(11):11D-16D. PubMed ID: 1372785
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of calcium antagonists.
Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
[TBL] [Abstract][Full Text] [Related]
3. SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.
Hara Y; Nakaya H
Br J Pharmacol; 1995 Nov; 116(6):2750-6. PubMed ID: 8591000
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of calmodulin and protein kinase C by amiodarone and other class III antiarrhythmic agents.
Silver PJ; Connell MJ; Dillon KM; Cumiskey WR; Volberg WA; Ezrin AM
Cardiovasc Drugs Ther; 1989 Oct; 3(5):675-82. PubMed ID: 2488107
[TBL] [Abstract][Full Text] [Related]
5. Bepridil blunts the shortening of action potential duration caused by metabolic inhibition via blockade of ATP-sensitive K(+) channels and Na(+)-activated K(+) channels.
Li Y; Sato T; Arita M
J Pharmacol Exp Ther; 1999 Nov; 291(2):562-8. PubMed ID: 10525072
[TBL] [Abstract][Full Text] [Related]
6. Bepridil hydrochloride alters potential-dependent and receptor-operated calcium channels in vascular smooth muscle of rabbit aorta.
Flaim SF; Ratz PH; Swigart SC; Gleason MM
J Pharmacol Exp Ther; 1985 Jul; 234(1):63-71. PubMed ID: 2409274
[TBL] [Abstract][Full Text] [Related]
7. Bepridil blockade of Ca2+-dependent action potentials in vascular smooth muscle of dog coronary artery.
Harder DR; Sperelakis N
J Cardiovasc Pharmacol; 1981; 3(4):906-14. PubMed ID: 6167820
[TBL] [Abstract][Full Text] [Related]
8. Chloride dependent intracellular pH increase induced by bepridil in human red blood cells: a possible involvement in correction of ischemic acidosis.
Kovacic H; Gallice P; Sarrazin M; Crevat A
J Pharmacol Exp Ther; 1993 Dec; 267(3):1509-14. PubMed ID: 8263812
[TBL] [Abstract][Full Text] [Related]
9. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
Barron E; Marshall RJ; Martorana M; Winslow E
Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
[TBL] [Abstract][Full Text] [Related]
10. Investigations on calmodulin antagonistic effects of bepridil in intact and skinned fibres of smooth muscle.
Reiermann HJ; Rüegg JC
Arzneimittelforschung; 1986 Apr; 36(4):668-70. PubMed ID: 3487326
[TBL] [Abstract][Full Text] [Related]
11. Short- and long-term inhibition of cardiac inward-rectifier potassium channel current by an antiarrhythmic drug bepridil.
Ma F; Takanari H; Masuda K; Morishima M; Ono K
Heart Vessels; 2016 Jul; 31(7):1176-84. PubMed ID: 26498939
[TBL] [Abstract][Full Text] [Related]
12. Cardiac actions of taurine as a modulator of the ion channels.
Satoh H
Adv Exp Med Biol; 1998; 442():121-8. PubMed ID: 9635023
[TBL] [Abstract][Full Text] [Related]
13. Bepridil block of cardiac calcium and sodium channels.
Yatani A; Brown AM; Schwartz A
J Pharmacol Exp Ther; 1986 Apr; 237(1):9-17. PubMed ID: 2420970
[TBL] [Abstract][Full Text] [Related]
14. Effects of bepridil on cardiac electrophysiologic properties.
Prystowsky EN
Am J Cardiol; 1992 Apr; 69(11):63D-67D. PubMed ID: 1553893
[TBL] [Abstract][Full Text] [Related]
15. The effects of reported Ca2+ sensitisers on the rates of Ca2+ release from cardiac troponin C and the troponin-tropomyosin complex.
Smith SJ; England PJ
Br J Pharmacol; 1990 Aug; 100(4):779-85. PubMed ID: 2207500
[TBL] [Abstract][Full Text] [Related]
16. Bepridil, a class IV antiarrhythmic agent, can block the TREK-1 potassium channel.
Wang Y; Fu Z; Ma Z; Li N; Shang H
Ann Transl Med; 2021 Jul; 9(14):1123. PubMed ID: 34430564
[TBL] [Abstract][Full Text] [Related]
17. Effects of bepridil and CERM 4205 (ORG 30701) on the relation between cardiac cycle length and QT duration in healthy volunteers.
Lecocq B; Lecocq V; Prost PL; Fleurot O; Boisson P; Jaillon P
Am J Cardiol; 1990 Sep; 66(5):636-41. PubMed ID: 2203243
[TBL] [Abstract][Full Text] [Related]
18. Effects on calmodulin of bepridil, an antianginal agent.
Itoh H; Ishikawa T; Hidaka H
J Pharmacol Exp Ther; 1984 Sep; 230(3):737-41. PubMed ID: 6088765
[TBL] [Abstract][Full Text] [Related]
19. [Modulation of coronary vessel tonus: molecular and cellular mechanisms].
Busse R; Bassenge E
Z Kardiol; 1984 Aug; 73(8):477-91. PubMed ID: 6093397
[TBL] [Abstract][Full Text] [Related]
20. Bepridil differentially inhibits two delayed rectifier K(+) currents, I(Kr) and I(Ks), in guinea-pig ventricular myocytes.
Wang JC; Kiyosue T; Kiriyama K; Arita M
Br J Pharmacol; 1999 Dec; 128(8):1733-8. PubMed ID: 10588929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
